Our Services
Medical Information
Helpful Resources
Published on: 4/24/2026
Diarrhea is common after starting Wegovy due to slowed stomach emptying, dietary shifts, and hydration changes.
However, if diarrhea lasts over two weeks, exceeds six loose stools in 24 hours, or involves blood, severe pain, fever, or dehydration you should seek medical advice. There are several factors to consider; see below for the complete checklist and next steps.
Starting Wegovy (semaglutide) can bring welcome changes in weight and appetite, but it may also trigger gastrointestinal side effects—diarrhea being one of the more common ones. Understanding when diarrhea is a normal adjustment and when it could signal something more serious is key to staying safe and on track with your treatment.
Wegovy belongs to a class of medications called GLP-1 receptor agonists. They work by slowing stomach emptying, reducing appetite, and improving blood sugar control. As your gut adapts, you may notice changes in stool consistency and frequency.
Common reasons for diarrhea after starting Wegovy include:
Most people experience mild to moderate diarrhea in the first few weeks or at dose increases. In many cases, it improves as your body adapts.
While mild diarrhea can be expected, certain warning signs suggest you should pause and seek medical advice:
If you experience any of these, speak to a healthcare professional promptly.
Use this checklist to decide if your diarrhea falls within the "expected side effect" range or if it could be something more serious:
Timing
Frequency & consistency
Associated symptoms
Dietary factors
Hydration & electrolytes
If most of your answers align with mild, temporary side effects, you can likely manage diarrhea at home. If you check any red-flag items above, reach out to your doctor.
Even when diarrhea is expected, it can be uncomfortable. Try these strategies to ease symptoms:
Dietary adjustments
• Follow a BRAT diet (bananas, rice, applesauce, toast) for a brief period.
• Avoid high-fat, spicy, or very sugary foods that can worsen diarrhea.
• Limit sugar-free gums, candies, and drinks with sugar alcohols (e.g., sorbitol, xylitol).
Hydration
• Sip water, diluted fruit juice, or oral rehydration solutions throughout the day.
• Aim for pale, straw-colored urine.
Fiber balance
• Introduce soluble fiber (oats, bananas, apples without peel) gradually.
• Hold off on large servings of insoluble fiber (bran, raw vegetables) until symptoms improve.
Over-the-counter remedies
• Loperamide (Imodium) can reduce frequency for short-term relief.
• Probiotics (Lactobacillus or Bifidobacterium strains) may help restore gut balance.
Medication review
• Check with your doctor if any other prescriptions or supplements could contribute.
• Your provider may advise slowing dose escalation if diarrhea is severe.
Even if you follow the above tips, persistent or severe diarrhea can lead to dehydration, electrolyte imbalances, and nutrient deficiencies. Always consider:
Your healthcare team can rule out infections, adjust your Wegovy dose, or recommend other interventions.
Diarrhea after starting Wegovy is common, especially during dose increases or dietary shifts. In most cases, it's mild and resolves as your body adapts. Keeping an eye on severity, duration, and associated symptoms helps you decide between home care and medical evaluation.
Above all, if you encounter any life-threatening or serious symptoms—such as severe dehydration, bloody stools, or intense pain—speak to a doctor right away. A prompt evaluation ensures safe, effective use of Wegovy on your journey to better health.
(References)
* Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021 Mar 18;384(11):989-1002. doi: 10.1056/NEJMoa2032183. Epub 2021 Feb 10. PMID: 33567185.
* Hjerpe A, Zethelius B, Jansson T. Glucagon-like peptide-1 receptor agonists and gastrointestinal adverse events: A review. World J Diabetes. 2023 Feb 15;14(2):63-75. doi: 10.4239/wjd.v14.i2.63. PMID: 36814981; PMCID: PMC9939520.
* Davies MJ, Færch K, Jeppesen OK, et al. Efficacy and safety of oral semaglutide in patients with type 2 diabetes: a pooled analysis of the PIONEER clinical trial programme. Diabetes Obes Metab. 2021 Jan;23(1):164-173. doi: 10.1111/dom.14207. Epub 2020 Oct 11. PMID: 33043685; PMCID: PMC7890731.
* Lingvay I, Hansen T, Kumar H, et al. Management of gastrointestinal adverse events with oral semaglutide. Diabetes Obes Metab. 2021 May;23(5):1079-1088. doi: 10.1111/dom.14324. Epub 2021 Feb 15. PMID: 33586111; PMCID: PMC8154564.
* Rubino DM, Greenway FL, Khalid U, et al. Effect of Continued Weekly Dosing of Semaglutide After Reaching a Target Dose on Weight Loss in Adults With Overweight or Obesity: The STEP 7 Randomized Clinical Trial. JAMA. 2023 Aug 15;330(7):643-652. doi: 10.1001/jama.2023.11666. PMID: 37581977; PMCID: PMC10431327.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.